Gilead Sciences, Inc`s Profile
This article summarizes the perfomance of the assignee in the recent years. The overall statistics for this portfolio help to analyze the areas where the assignee is performing well. The filing trend, perfomance across the tech centers and the perfomance of the recent applications has been mentioned below. All the stats are calculated based on the perfomance in USPTO.
How does the overall patent portfolio of Gilead Sciences, Inc look like?
|Grant Index||85.71 %|
|Abandoned/Rejected Applications:||1 (14.29%)|
|Average Grant Time:||2.95 Years|
|Average Office Actions:||2.0|
Which Technology Area Gilead Sciences, Inc is filing most patents in? (Last 10 years)
|Art Unit||Definition||Total Applications|
|1634||Molecular Biology, Bioinformatics, Nucleic Acids, Recombinant DNA and RNA, Gene Regulation, Nucleic Acid Amplification, Animals and Plants, Combinatorial/ Computational Chemistry||3|
|1655||Fermentation, Microbiology, Isolated and Recombinant Proteins/Enzymes||2|
|1637||Molecular Biology, Bioinformatics, Nucleic Acids, Recombinant DNA and RNA, Gene Regulation, Nucleic Acid Amplification, Animals and Plants, Combinatorial/ Computational Chemistry||1|
How many patents are Gilead Sciences, Inc filing every year?
*The drop in the number of applications filed in last two years compared to previous years is because applications can take up to 18 months to get published
Recently filed patent applications of Gilead Sciences, Inc in USPTO?
Publication date: –
Applicant: Gilead Sciences, Inc
Inventors: Joanna Koziara
How are Gilead Sciences, Inc’s applications performing in USPTO?
|Application Number||Title||Status||Art Unit||Examiner|
|62296524||Pharmaceutical Formulations||Provisional Application Expired||–||–|